WASHINGTON, Sept. 26, 2016 -- Inovalon (NASDAQ:INOV), a leading technology company providing advanced, cloud-based analytics and data-driven intervention platforms to the healthcare industry, is hosting its 2016 Client Congress this week at The Ritz Carlton in Washington, D.C. The prestigious two-day event, Sept. 25-27, features keynote speakers from across the healthcare industry.
“Healthcare continues to evolve in exciting and innovative ways, and for eight years we’ve been fortunate to host the industry leaders who are helping drive this change,” said Robert Wychulis, president of Inovalon. “This year, we’ve once again assembled change-makers from across healthcare who will address the many ways that technology innovations are expanding the healthcare industry’s access to actionable insights and driving positive impact at extraordinary speed.”
Now in its eighth year, Client Congress features notable keynote speakers, including Vindell Washington, M.D., M.H.C.M., F.A.C.E.P., national coordinator of health information technology for the U.S. Department of Health and Human Services; Adaeze Enekwechi, Ph.D., M.P.P., associate director of health programs for the Office of Management & Budget under President Obama; Daniel Mendelson, president of Avalere Health; Peggy O’Kane, founder and president of the National Committee for Quality Assurance (NCQA); Marilyn Tavenner, president and chief executive officer of America’s Health Insurance Plans (AHIP) and former Administrator of the Centers for Medicare and Medicaid Services; Lori Reilly, executive vice president of policy and research for Pharmaceutical Research and Manufacturers of America (PhRMA); and Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon.
As the shift from volume to value continues to drive industry-wide change within government-led initiatives and private sector programs alike, Client Congress expert speakers and panelists will provide meaningful insight into the current healthcare landscape, and how data and its analysis is driving insights and improvement in care, quality outcomes, and financial performance throughout the industry.
The 2016 conference will once again be moderated by Susan Dentzer, president and chief executive officer for the Network for Excellence in Health Innovation and on-air health policy analyst for PBS News Hour.
Attendees include hundreds of industry executives who manage and influence the healthcare continuum, including health plans, provider organizations, pharma/life sciences, government agencies, and technology innovators.
About Inovalon
Inovalon is a leading technology company that combines advanced, cloud-based data analytics, and data-driven intervention platforms to achieve meaningful insight and impact in clinical and quality outcomes, utilization and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, data-driven intervention platforms and deep subject matter expertise deliver a seamless, end-to-end capability that brings the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity and financial performance – while bringing to bear the unique capabilities to resolve them. Providing technology that supports hundreds of healthcare organizations in 98.4 percent of U.S. counties and Puerto Rico, Inovalon's cloud-based analytical and data-driven intervention platforms are informed by data pertaining to more than 804,000 physicians, 306,000 clinical facilities and more than 137 million Americans. Through these capabilities, and those of its subsidiary Avalere Health, Inc., which offers data-driven advisory services and business intelligence to more than 200 pharmaceutical and life sciences enterprises, Inovalon is able to drive high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers. For more information, visit www.inovalon.com.
Contacts: Inovalon Kim E. Collins Phone: 301-809-4000 x1473 [email protected]


Shell M&A Chief Exits After BP Takeover Proposal Rejected
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
OpenAI Explores Massive Funding Round at $750 Billion Valuation
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 



